one hundred and seventy-one patients with advanced soft tissue sarcoma entered a randomized crossover phase ii study comparing cyclophosphamide ( cyclo ) with a new analogue , ifosfamide ( ifos ) , both administered as 24 h i.v . infusions every 3 weeks .
C0010583
cyclophosphamide
C0020823
ifosfamide